UCB Acquires Neurona Therapeutics in $1.15 Billion Deal

Covington has advised UCB. Wilson Sonsini Goodrich & Rosati has advised Neurona Therapeutics. UCB, a global biopharmaceutical company, has entered into a definitive agreement to acquire…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here